Description
Several Zika virus (ZIKV) vaccine candidates have recently been described which use inactivated whole virus, DNA or RNA that express the virus’ Envelope (E) glycoprotein as the antigen.
Copyright Statement
Reuse Permissions
Download count: 0
Details
Contributors
- Yang, Ming (Author)
- Lai, Huafang (Author)
- Sun, Haiyan (Author)
- Chen, Qiang (Author)
- ASU Biodesign Center Immunotherapy, Vaccines and Virotherapy (Contributor)
- Biodesign Institute (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2017-08-09
Resource Type
Collections this item is in
Identifier
- Digital object identifier: 10.1038/s41598-017-08247-9
- Identifier TypeInternational standard serial numberIdentifier Value2045-2322
Note
- The final version of this article, as published in Scientific Reports, can be viewed online at: https://www.nature.com/articles/s41598-017-08247-9, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Yang, M., Lai, H., Sun, H., & Chen, Q. (2017). Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Scientific Reports, 7(1). doi:10.1038/s41598-017-08247-9